HOXB9 and lung carcinoma: These data strongly suggest that targeting β-catenin in lung cancer with high expression of GalNAc-T14, which sensitizes lung cancer cells to Wnt, leading to HOXB9 expression, would be a valid approach to suppress HOXB9-dependent metastatic potential.